Q4 2024 Management View CEO Jim Hollingshead highlighted the company’s achievement of $2.1 billion in revenue for 2024, marking a doubling of revenue in just three years. He emphasized the strong ...

As we celebrate 25 years of Insulet, I want to acknowledge our global ... We continue to drive strong Omnipod 5 growth in the U.K. and Germany. We're also pleased with the early momentum we ...

Insulet’s Q4 revenue hit $597.5 million, up 17.2%, beating the $582.81 million consensus. Omnipod revenue climbed 16.9% to $585.7 million, with international sales up 33.5%. Get two weeks of ...

Feb 20(Reuters) - Insulet (PODD.O), opens new tab reported a higher-than-expected profit in the fourth quarter on Thursday, driven by strong demand for its wearable insulin pumps. The company ...

Insulet (PODD) came out with quarterly earnings of $1.15 per share, beating the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $1.40 per share a year ago. These figures ...

In the preceding three months, 6 analysts have released ratings for Insulet PODD, presenting a wide array of perspectives from bullish to bearish. The table below provides a concise overview of ...

Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be announcing earnings results tomorrow after market close. Here’s what to expect. Insulet beat analysts’ revenue expectations ...